Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ: NARI )

79.45 +14.45 (+22.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,470,541
Open 78.97
Bid (Size) 79.38 (1)
Ask (Size) 79.45 (2)
Prev. Close 65.00
Today's Range 78.85 - 79.50
52wk Range 36.81 - 79.50
Shares Outstanding 54,313,676
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
From Kahn Swick & Foti, LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
+53.38%
+53.38%
1 Month
+48.81%
+48.81%
3 Month
+87.38%
+87.38%
6 Month
+55.36%
+55.36%
1 Year
+21.11%
+21.11%

More News

Read More
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Via Benzinga
Demystifying Inari Medical: Insights From 6 Analyst Reviews
Via Benzinga
Key Takeaways From Inari Medical Analyst Ratings
Via Benzinga
Inari Medical's Earnings: A Preview
Via Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Inari Medical Catapults 30% On Rumored Stryker Takeover
Via Investor's Business Daily
Inari Medical to Present at the J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Breaking Down Inari Medical: 9 Analysts Share Their Views
Via Benzinga
Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts
Via Benzinga
Inari Medical Stock Gets RS Rating Upgrade
Via Investor's Business Daily
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Joint Venture in Greater China
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Participate in the Jefferies London Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
From Inari Medical, Inc.
Via GlobeNewswire
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Inari Medical Reports Third Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Third Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
From Inari Medical, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.